SCHEMBL27220652

SCHEMBL27220652

COc1ccncc1CNC(=O)c1cnc(OC(F)F)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.43
▸ ROCK2 O75116 5/20 0.42
▸ SLC2A1 P11166 1/20 0.42
▸ CDK2 P24941 1/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ EPHX2 P34913 1/20 0.40
▸ SCN9A Q15858 1/20 0.40
▸ ROCK1 Q13464 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ HSD17B13 Q7Z5P4 1/20 0.40
▸ TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29896160 1.00 POLB (0.43) POLBROCK2SLC2A1CDK2GSK3B
SCHEMBL29896172 0.93 MAPT (0.41) POLBROCK2GSK3BALDH1A1EPHX2
SCHEMBL27188857 0.93 MAPT (0.41) POLBROCK2GSK3BALDH1A1EPHX2
SCHEMBL23143270 0.89 POLB (0.44) POLBROCK2GSK3BUSP2ALDH1A1
SCHEMBL29896088 0.89 POLB (0.44) POLBROCK2GSK3BUSP2ALDH1A1
SCHEMBL29896176 0.88 PIK3CA (0.42) ROCK2SLC2A1HSD17B13
SCHEMBL27188849 0.88 PIK3CA (0.42) ROCK2SLC2A1HSD17B13
SCHEMBL29896099 0.85 SCN9A (0.39) POLBROCK2CDK2GSK3BALDH1A1
SCHEMBL23143259 0.85 SCN9A (0.39) POLBROCK2CDK2GSK3BALDH1A1
SCHEMBL29896103 0.81 GAA (0.41) POLBROCK2GSK3BEPHX2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4034257-B1 HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICALS CO (JP) 2024-05-22 — — EP claimed
EP-4034257-B1 HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICALS CO (JP) 2024-05-22 — — EP disclosed
Send feedback